BIOCELTIX S.A. ZY -10 (XI3) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.062x

Based on the latest financial reports, BIOCELTIX S.A. ZY -10 (XI3) has a cash flow conversion efficiency ratio of -0.062x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-4.54 Million ≈ $-5.31 Million USD) by net assets (€73.28 Million ≈ $85.67 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIOCELTIX S.A. ZY -10 (XI3) balance sheet quality index to measure how much of total assets are equity-financed.

BIOCELTIX S.A. ZY -10 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how BIOCELTIX S.A. ZY -10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore BIOCELTIX S.A. ZY -10 (XI3) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

BIOCELTIX S.A. ZY -10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BIOCELTIX S.A. ZY -10 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Adda Corporation TWO:3071	0.068x
United Bancorp Inc NASDAQ:UBCP	0.005x
ChampionsGate Acquisition Corporation Class A Ordinary Share NASDAQ:CHPG	0.000x
Shemen Industries Ltd TA:SMNIN	-0.015x
Scope Fluidics SA WAR:SCP	-0.102x
Arq Inc NASDAQ:ARQ	0.001x
Tillys Inc NYSE:TLYS	0.101x
CURATIS N AG SW:CURN	-0.024x

Annual Cash Flow Conversion Efficiency for BIOCELTIX S.A. ZY -10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of BIOCELTIX S.A. ZY -10 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see XI3 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€73.28 Million ≈ $85.67 Million	€-11.95 Million ≈ $-13.97 Million	-0.163x	+64.34%
2024-12-31	€38.42 Million ≈ $44.91 Million	€-17.57 Million ≈ $-20.54 Million	-0.457x	+67.55%
2023-12-31	€10.47 Million ≈ $12.24 Million	€-14.75 Million ≈ $-17.24 Million	-1.409x	+7.84%
2022-12-31	€5.15 Million ≈ $6.02 Million	€-7.87 Million ≈ $-9.21 Million	-1.529x	-128.26%
2021-12-31	€6.00 Million ≈ $7.01 Million	€-4.02 Million ≈ $-4.70 Million	-0.670x	--

About BIOCELTIX S.A. ZY -10

F:XI3 Germany Biotechnology

Market Cap

$116.29 Million

€99.47 Million EUR

Market Cap Rank

#19558 Global

#1804 in Germany

Share Price

€17.98

Change (1 day)

+0.45%

52-Week Range

€14.08 - €28.60

All Time High

€28.60